Ingevity Corporation
NYSE:NGVT · New York Stock Exchange
+$0.81 today
Vol 0.21M · Avg 0.26M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$150.3M +65.1% | -$430.3M -7868.5% | -$5.4M -102.6% | $211.6M +79.2% | $118.1M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $106.4M -1.8% | $108.3M -11.8% | $122.8M +12.9% | $108.8M -1.0% | $109.9M | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | -$4.7M +96.1% | -$121.4M -171.6% | -$44.7M -794.0% | -$5.0M -8.7% | -$4.6M | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $18.3M +53.8% | $11.9M +12.3% | $10.6M -34.2% | $16.1M +30.9% | $12.3M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | $15.0M +7600.0% | -$200.0K +99.9% | -$140.7M -111.6% | -$66.5M -318.0% | $30.5M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | $12.2M -68.1% | $38.2M -10.5% | $42.7M +201.4% | -$42.1M -205.1% | -$13.8M | $592.6M | $1.3B | $626.2M |
| Inventory | $40.2M -53.4% | $86.2M +214.0% | -$75.6M -18.7% | -$63.7M -14.2% | -$55.8M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | -$2.6M +95.9% | -$63.4M -334.2% | -$14.6M -134.2% | $42.7M +188.5% | $14.8M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | -$34.8M +43.1% | -$61.2M +34.3% | -$93.2M -2641.2% | -$3.4M -104.0% | $85.3M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $346.5M -38.2% | $560.3M +113.4% | $262.5M +442.4% | $48.4M +78.6% | $27.1M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $331.2M +157.5% | $128.6M -37.3% | $205.1M -34.6% | $313.4M +6.9% | $293.3M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$57.7M +25.6% | -$77.6M +29.3% | -$109.8M +22.9% | -$142.5M -37.3% | -$103.8M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $0 | $0 | $0 +100.0% | -$344.5M | $0 | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | -$16.4M -5366.7% | -$300.0K +87.5% | -$2.4M +96.9% | -$77.4M -119.3% | -$35.3M | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $0 | $0 -100.0% | $31.5M +114.3% | $14.7M | $0 | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $16.6M +1137.5% | -$1.6M -147.1% | $3.4M +254.5% | -$2.2M -540.0% | $500.0K | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$57.5M +27.7% | -$79.5M -2.8% | -$77.3M +86.0% | -$551.9M -298.2% | -$138.6M | $4.8B | $6.4B | $5.1B |
| Debt Repayment | -$193.6M -188.5% | -$67.1M -819.2% | -$7.3M -103.7% | $199.0M +865.4% | -$26.0M | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $1.4M | $0 | $0 | $0 | $0 | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | -$56.3M | $0 +100.0% | -$92.1M +36.6% | -$145.2M -32.7% | -$109.4M | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$3.7M -19.4% | -$3.1M -520.0% | -$500.0K +91.2% | -$5.7M -347.8% | $2.3M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | -$252.2M -259.3% | -$70.2M +29.7% | -$99.9M -307.7% | $48.1M +136.1% | -$133.1M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $4.5M +207.1% | -$4.2M -1300.0% | -$300.0K +95.0% | -$6.0M -252.9% | -$1.7M | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | $26.0M +202.8% | -$25.3M -191.7% | $27.6M +114.1% | -$196.4M -1086.9% | $19.9M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | $273.5M +436.3% | $51.0M -46.5% | $95.3M -44.2% | $170.9M -9.8% | $189.5M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Elevra Lithium Limited
NASDAQ:ELVR
$6.44B
Skeena Resources Limited
NYSE:SKE
$3.57B
The Chemours Company
NYSE:CC
$3.28B
Allied Gold Corporation
NYSE:AAUC
$3.24B
Ashland Inc.
NYSE:ASH
$3.05B
Quaker Chemical Corporation
NYSE:KWR
$2.60B
Olin Corporation
NYSE:OLN
$2.50B
Minerals Technologies Inc.
NYSE:MTX
$2.41B
Innospec Inc.
NASDAQ:IOSP
$2.05B
FMC Corporation
NYSE:FMC
$1.42B
SEC Filings
Recent regulatory filings
No filings found.
Does NGVT generate free cash flow?
Ingevity Corporation (NGVT) generated $273.50M of free cash flow in fiscal 2025.
How much operating cash flow does NGVT produce?
Operating cash flow was $331.20M, before capital expenditures of $57.70M.
Explore More
Continue the stock analysis
Jump to another research area for this company.